Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice
Open accessAbstract
Background and Purpose—: Bone marrow stromal cells (BMSC) decrease neurological deficits in rodents after stroke and concomitantly induce extensive neurite remodeling in the brain, which highly correlates with the improvement of neurological function. We investigated the effects of endogenous tissue plasminogen activator (tPA) on neurite remodeling after BMSC treatment. Methods—: Adult C57BL/6 wild-type (WT) mice and tPA knockout (tPA −/− ) mice were subjected to middle cerebral artery occlusion, followed by an injection of 1×10 6 BMSC (n=18) or phosphate-buffered saline (n=18) into the tail vein 24 hours later. Behavioral tests were performed at 3, 7, and 14 days after middle cerebral artery occlusion. Animals were euthanized at 14 days after stroke. Results—: The effects of BMSC on functional recovery depended on presence or absence of tPA, even after adjusting for imbalanced stroke severity. BMSC significantly improve functional recovery in WT mice compared to WT controls but show no beneficial effect in the tPA −/− mice compared to tPA −/− controls. Axonal density and synaptophysin-positive areas along the ischemic boundary zone of the cortex and striatum in WT mice are significantly higher than in the tPA −/− mice. BMSC treatment significantly increases tPA protein level and activity only in WT mice. Conclusions—: Our results suggest that endogenous tPA promotes BMSC-induced neurite outgrowth and may contribute to functional recovery after stroke.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Delivery of bone-marrow-derived stromal cells or mesenchymal stromal cells further increases levels of GDNF and tPA and reduces levels of tPA inhibitor PAI-1.
“Delivery of bone-marrow-derived stromal cells or mesenchymal stromal cells was shown to further increase levels of GDNF66 and tPA68,69 and reduce levels of the tPA inhibitor plasminogen activator inhibitor 1.70”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 56 · Cited by 51
- Authors
- Shen, L. H., Xin, H., Li, Y., Zhang, R. L., Cui, Y., Zhang, L., Lu, M., Zhang, Z. G., & Chopp, M.
- Affiliations
- Henry Ford Health (US)
- From the Departments of Neurology (L.H.S., H.X., Y.L., R.L.Z., Y.C., L.Z., Z.G.Z., M.C.) and Biostatistics and Research Epidemiology (M.L.), Henry Ford Hospital, Detroit, MI; Department of Physics (M.C.), Oakland University, Rochester, MI.
- Venue
- Stroke
- Published
- 2011-02
- Volume
- 42
- Issue
- 2
- Pages
- 459-464
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- PMC
- PMC3093714
- OpenAlex
- W2149005224
- Cited by
- 51
- References
- 56
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 3 · 2014: 6 · 2013: 7 · 2012: 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (P01NS42345, R01NS066041, P01NS042345)
- Topics
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Keywords
- tissue plasminogen activator, mesenchymal stem cells, middle cerebral artery occlusion, functional recovery, axon density, synaptophysin, cell therapy
- MeSH terms
- Animals, Bone Marrow Cells, Male, Mice, Inbred C57BL, Tissue Plasminogen Activator, Bone Marrow Transplantation, Neurites, Stromal Cells, Mice, Knockout, Recovery of Function, Stroke, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review